Mirae Asset Global Investments’s Charles River Laboratories CRL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.72M	Buy	9,992 +1,715	+21%	+$318K	﹤0.01%	768
2025 Q4	$1.65M	Buy	8,277 +1,192	+17%	+$216K	﹤0.01%	819
2025 Q3	$1.11M	Buy	7,085 +633	+10%	+$101K	﹤0.01%	868
2025 Q2	$979K	Buy	6,452 +334	+5%	+$44.5K	﹤0.01%	836
2025 Q1	$952K	Buy	6,118 +817	+15%	+$137K	﹤0.01%	822
2024 Q4	$987K	Buy	5,301 +1,679	+46%	+$323K	﹤0.01%	820
2024 Q3	$718K	Sell	3,622 -1,137	-24%	-$236K	﹤0.01%	891
2024 Q2	$987K	Sell	4,759 -5,954	-56%	-$1.35M	﹤0.01%	766
2024 Q1	$2.6M	Sell	10,713 -4,045	-27%	-$966K	0.01%	1071
2023 Q4	$3.5M	Sell	14,758 -638	-4%	-$125K	0.01%	1025
2023 Q3	$3.01M	Sell	15,396 -3,693	-19%	-$758K	0.01%	1017
2023 Q2	$4M	Buy	19,089 +479	+3%	+$95.3K	0.01%	956
2023 Q1	$3.72M	Buy	18,610 +2,207	+13%	+$500K	0.01%	949
2022 Q4	$3.61M	Buy	16,403 +4,123	+34%	+$900K	0.01%	922
2022 Q3	$2.38M	Buy	+12,280	New	+$2.65M	0.01%	1064
2021 Q4	–	Sell	-1,715	Closed	-$707K	–	1609
2021 Q3	$707K	Buy	1,715 +550	+47%	+$228K	﹤0.01%	1406
2021 Q2	$431K	Buy	+1,165	New	+$389K	﹤0.01%	1493
2019 Q3	–	Sell	-8,420	Closed	-$1.2M	–	1430
2019 Q2	$1.2M	Buy	+8,420	New	+$1.14M	0.01%	853